Optipharm.CO.LTD Cash Flow Reinvestment Rate
Optipharm.CO.LTD cash flow reinvestment rate. Optipharm.CO.LTD (153710) has a Cash Flow Reinvestment Rate of 1.27x as of June 2026, reinvesting ₩1.15 Billion (capex ₩130.67 Million plus investments ₩1.02 Billion) from operating cash flow of ₩905.29 Million. Explore how well can Optipharm.CO.LTD service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Optipharm.CO.LTD (2016–2019)
Cash flow reinvestment rate of Optipharm.CO.LTD from 2016 to 2019. Historical reinvestment intensity for Optipharm.CO.LTD across 4 annual periods. Explore Optipharm.CO.LTD capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Optipharm.CO.LTD Cash Flow Reinvestment Rate by Year (2016–2019)
Optipharm.CO.LTD cash flow reinvestment rate by year from 2016 to 2019. Year-by-year capital reinvestment analysis for Optipharm.CO.LTD. For the full cash flow conversion analysis, see how efficiently does Optipharm.CO.LTD generate cash.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 13.02x | ₩5.83 Billion | ₩447.47 Million | ₩626.46 Million | ▲ +6121.0% |
| 2018 | 0.21x | ₩251.91 Million | ₩1.20 Billion | ₩202.91 Million | ▼ -92.4% |
| 2017 | 2.77x | ₩722.33 Million | ₩260.86 Million | ₩670.33 Million | ▲ +473.4% |
| 2016 | 0.48x | ₩415.95 Million | ₩861.36 Million | ₩391.95 Million | — |